Summary
To assess the potential of Drosophila to analyze clinically graded aspects of human disease, we developed a transgenic fly model to characterize Presenilin (PS) gene mutations that cause early-onset familial Alzheimer's disease (FAD). FAD exhibits a wide range in severity defined by ages of onset from 24 to 65 years [1] . PS FAD mutants have been analyzed in mammalian cell culture, but conflicting data emerged concerning correlations between age of onset and PS biochemical activity [2] [3] [4] . Choosing from over 130 FAD mutations in Presenilin-1, we introduced 14 corresponding mutations at conserved residues in Drosophila Presenilin (Psn) and assessed their biological activity in transgenic flies by using genetic, molecular, and statistical methods. Psn FAD mutant activities were tightly linked to their age-of-onset values, providing evidence that disease severity in humans primarily reflects differences in PS mutant lesions rather than contributions from unlinked genetic or environmental modifiers. Our study establishes a precedent for using transgenic Drosophila to study clinical heterogeneity in human disease.
Results and Discussion
Presenilin is an evolutionarily conserved polytopic membrane protein that is part of the multisubunit g-secretase complex responsible for intramembranous cleavage of several transmembrane proteins, including APP, Notch, Delta, DCC, ErbB4, N-Cadherin, and E-Cadherin [5] . Familial Alzheimer's disease (FAD) mutations in Presenilin-1 (PS1) and PS2 alter proteolytic processing of APP to generate more toxic Ab42 peptides that accelerate amyloid plaque formation in brain tissues [6] . PS mutations also contribute to neurodegeneration and cognitive decline through amyloid-independent mechanisms [7] , involving altered regulation of receptor signaling and intracellular kinase pathways [7] [8] [9] [10] .
The Drosophila APP ortholog, APPL, lacks homology to APP within the Ab peptide region, and loss of APPL produces subtle behavioral deficits that are difficult to measure quantitatively [11] . A more suitable substrate to monitor Presenilin (Psn) FAD mutant activity in Drosophila is the Notch receptor, the most extensively characterized fly g-secretase substrate. Psn is required throughout Drosophila development for Notch signaling, and a wide variety of Notch-related phenotypes exist that range from severe embryonic lethality to specific defects in adult tissues. This phenotypic range is amenable to characterizing variable degrees of function among different Psn FAD mutants. In addition, genetic and molecular reagents are available to characterize Notch biochemical cleavage and subsequent targetgene activation in Drosophila.
Previous studies have successfully used transgenic mice and C. elegans to assess the genetic properties of human PS FAD mutants [12] [13] [14] [15] , and one study suggested a potential difference between two FAD variants [14] . However, quantitative comparison between FAD mutants was not practical because of heterologous expression methods and difficulties controlling transgene copy numbers. Two studies in mammalian cell culture showed little or no relationship between average ages of onset and Ab42 secretion levels [3, 4] , contrary to one study reporting a strong correlation [2] .
We assessed PS FAD mutant function in Drosophila by expressing 14 FAD-linked mutant psn transgenes in animals lacking endogenous psn function. The mutations were selected on the basis of the following criteria: (1) they span the entire protein ( Figure 1A ), (2) relatively large numbers of families and affected individuals have been identified for most mutations ( Figure 1B) , and (3) their ages of onset range from 24 to 65 years, or are possibly asymptomatic (E318G and F175S; Figure 1B ) [16] [17] [18] [19] . Thirteen of the mutations affect residues that are conserved in fly Psn, and the remaining one alters a conservatively substituted residue ( Figure 1A ). To achieve physiological expression of the transgenes, we defined a 1.5 kb promoter, termed PEPC (Presenilin endogenous promoter cassette), of the endogenous psn gene. At the larval-pupal transition, loss of psn function causes highly uniform lethality that is fully rescued by a wildtype PEPC-psn transgene but not by wild-type human PS1 or PS2 transgenes driven by PEPC (data not shown). To circumvent this technical problem with human PS transgenes, we engineered each FAD mutation into the fly psn gene.
Examining transgenic lines expressing PEPC-psn FAD mutants in a psn null genetic background, we defined eight distinct phenotypic categories that represent a graded series in order of increasing rescue ability, as follows: (1) prepupal lethal, (2) late prepupal lethal, (3) pupal lethal, (4) pharate lethal, (5) severe neurogenic/adult *Correspondence: fortini@ncifcrf.gov lethal, (6) moderate neurogenic/adult viable, (7) weak neurogenic/adult viable, and (8) morphologically normal ( Figure 2 ). Quantitative analysis of survival rates, incidence of dorsoscutellar bristle duplications, wing notching, wing vein defects, and other morphological features was performed to assign each transgenic line to the appropriate rescue category (see Table S1 in the Supplemental Data online for details of quantitative scoring).
The phenotypic categories are consistent with an ordered series attributable to progressive increases in Psn-dependent Notch activation, but it was important to verify that they do not instead represent the effects of Psn on other substrates. In the canonical Notch pathway, ligand binding to the Notch receptor leads to ectodomain removal and subsequent g-secretase-mediated intramembranous cleavage of Notch [20] . The liberated intracellular domain, termed NICD, translocates to the nucleus and participates directly in transcriptional regulation of target genes, including the Enhancer of split m7 (E(spl)m7) gene in Drosophila [21] . Activation of Notch signaling within proneural cell clusters destined to give rise to adult sensory organs results in restricted expression of the proneural marker scabrous (sca) [22] . Visualization of sca expression in the larval imaginal wing disc with a sca-lacZ transgene provides evidence for a progressive range of Notch signaling with different PEPCpsn transgenes ( Figures 2E-2H ).
Biochemical evidence for progressively increasing Psn function was obtained by immunoblot analysis of Notch cleavage products across the spectrum of PEPC-psn FAD phenotypes ( Figure 3 ). Representative PEPC-FAD transgenic lines of the different categories exhibit partial-to-complete failure in g-secretase-mediated NICD production. Interestingly, although transgenic lines belonging to categories 2-4 exhibit significant levels of biological rescue activity, they do not produce levels of NICD detectable by immunoblot analysis. These results demonstrate that genetic assays such as ours are valuable for studying low-level or tissue-specific aspects of g-secretase substrate cleavage that might not be amenable to biochemical analysis.
To determine whether the PEPC-psn FAD phenotypic series is similarly correlated with Notch target-gene activation, we used semiquantitative RT-PCR to monitor activation of the E(spl)m7 gene ( Figure 4 ). Normalizing transcriptional activation to two control genes, we observed a progressive increase in E(spl)m7 transcript levels across categories 1-8, confirming that they represent graded increases in g-secretase-dependent Notch activation. To verify this relationship, we utilized a temperature-sensitive Notch allele termed N ts1 . Incremental levels of Notch activity obtained by raising N ts1 flies at different temperatures produced phenotypes matching those seen in the Psn FAD mutant series, but were independent of manipulations involving endogenous or transgenic Psn. Levels of E(spl)m7 transcriptional activation seen in these N ts1 phenotypic classes resembled closely those observed in the corresponding PEPC-psn FAD classes, confirming the progressive increase in Notch target-gene activation across this phenotypic spectrum ( Figure 4 ). Taken together, these results validate the use of our phenotypic criteria to characterize varying degrees of PEPC-psn FAD transgene activity toward the endogenous g-secretase substrate Notch. A limitation of transgenic analysis in Drosophila is that the transgenes are inserted at essentially random genomic locations, leading to variations in expression as a result of local position effects at different sites. These effects are a confounding factor in our comparisons of relative degrees of rescue function, which reflects properties of the primary lesion in each Psn mutant protein as well as the expression level of each transgenic insertion. We therefore generated from four to 16 independent insertions for each transgene, and each insertion was scored with multiple quantitative morphological criteria and assigned to the appropriate phenotypic category (see above and Table S1 ). The resulting data for all 162 transgenic lines, representing 14 PEPC-psn FAD mutants and one wild-type Psn control construct, are graphically presented in Figure 5A . Visual inspection suggests a positive overall trend between increasing age of onset in human FAD pedigrees and increasing biological activity for these FAD mutants in transgenic Drosophila.
To investigate this potential trend, we applied a number of statistical tests to the transgenic scoring data. We used exclusively nonparametric tests that treat the data only as ordinally ranked categories. This conservative approach was used because age-of-onset figures are derived from relatively small human sample sizes, and we cannot affix quantitative values to the eight phenotypic rescue categories, although we are confident of their progressive ordinal ranking. The Jonckheere-Terpstra test [23] for ordered alternatives is a nonparametric test that fits these assumptions. For this analysis, the very-late-onset/probable asymptomatic mutants F175S and E318G were placed in a single group ordered prior to the wild-type Psn transgene. Using this test, we find a highly significant correlation between the age-of-onset ranking of the FAD mutants and the relative biological activities of the corresponding Psn mutant transgenes (p < 0.0001; J-T statistic = 6.9). We also analyzed the data with Spearman's rho [23] , a nonparametric test for correlation between two variables without the assumption of a linear relationship, which similarly demonstrates a highly significant correlation between age-ofonset values and biological activities in Drosophila (p < 0.0001; correlation = +0.531).
The above tests demonstrate an overall correlation across the dataset as a whole, but Figure 5A indicates that the correlation is not smooth. Most FAD mutants appear to cluster in groups separated by discontinuities, with a few mutants that are noticeably different from nearby mutants. To investigate these features, we performed pairwise rank-sum comparisons between all individual Psn FAD mutants with the Wilcoxon-MannWhitney test, a nonparametric method for analyzing the overlap between distributions of two independent groups [23] . We found that mutants having similar ages of onset are, in general, not statistically different from one another ( Figure 5B) . Nevertheless, the mutants can be statistically grouped into three distinct classes: strong (L166P, L173W Transcriptional activation of the Notch target gene E(spl)m7 (y axis) was monitored by RT-PCR across a representative sampling of Psn FAD transgenic lines covering the eight morphological categories (x axis). E(spl)m7 transcript levels were normalized to levels of Notch mRNA, because Notch signaling is sensitive to receptor dosage [26] and Notch transcription might thus be susceptible to perturbations in Psn activity. We confirmed RT-PCR results of E(spl)m7 normalized to Notch (blue symbols) with an independent RT-PCR using ribosomal-protein gene Rp49 (red symbols) for normalization. RT-PCR ratios for transgenic lines bearing a single-copy PEPC-psn FAD construct in a psn null background are indicated as circles; control genotypes are as follows: wild-type (red and blue diamonds), N ts1 flies raised at different temperatures (yellow squares), psn homozygote null (red and blue triangles), and psn heterozygotes (green diamond). Error bars represent 6 standard error of the mean.
E280A, A246E, and G206A; Figure 5E ), and weak (A79V, F175S, and E318G; Figure 5F ). Strong mutants differ most clearly from the weak ones in terms of function (Figures 5C and 5D) , and vice versa ( Figure 5F ), whereas the intermediate group shows more modest differences compared to either of these two flanking groups (Figure 5E ). Pairwise comparisons of aggregated mutant groups confirmed these classes. The strong mutant group is significantly different from both the intermediate and weak groups (p < 0.0001 in both cases). Despite its age of onset of w60, the A79V mutant is more similar to the weak mutants than the intermediate ones, as confirmed by pairwise comparisons of aggregated intermediate and weak groups with A79V assigned to either the intermediate (p = 0.0027) or the weak group (p = 0.00049).
Similarly, two mutants, L235P and P436Q, are less functional in transgenic flies than might be predicted on the basis of their ages of onset, whereas another mutant, M139V, is somewhat more functional than expected. Whether these disparities reflect inadequate age-of-onset data, modifier effects in the corresponding human pedigrees, or an unknown feature of the fly assay system is not clear. Finally, the E318G and F175S mutants, proposed to be either very weak pathogenic mutants or functionally normal polymorphisms, are statistically indistinguishable from the wild-type transgene in our genetic assay, consistent with the idea that they are nonpathogenic polymorphisms. Overall, our results support the assertion that disease severity in early-onset Alzheimer's disease is primarily determined by PS mutant lesion type as opposed to unlinked genetic or environmental modifiers, as was also deduced from a study of Ab secretion levels in PS FAD mutant transfected cells [2] .
A few other interesting patterns emerge from these comparisons. Mutants for which relatively few independent lines were obtained, most notably H163R (n = 4), fail to show significant differences when compared to other mutant groups (Figures 5C-5F ). On the basis of the complete dataset, we estimate that w10 independent lines of a given mutant are required to obtain statistically useful data. This problem might be circumvented by employing a ''knock in'' strategy to precisely replace the endogenous psn gene with FAD variants, an approach that is not yet reliable in Drosophila. Additionally, one source of experimental noise is that transgenes occasionally insert into locations where they are poorly expressed or damaged during insertion, as is evident from a few instances involving the ''asymptomatic'' F175S and E318G mutant and wild-type transgenes. Normalization of functional read-outs for each transgene insertion relative to its mRNA or protein expression level in the appropriate transcript null or protein null psn mutant background should reduce this noise and lead to further refinement of the statistical data.
Our findings establish the validity of using transgenic Drosophila or other heterologous organisms to evaluate clinically heterogeneous aspects of human diseases with a clearly defined genetic etiology. Transgenic Drosophila offer several advantages to augment more traditional clinical assessments as well as transgenic mouse models. Transgenic flies are relatively inexpensive and rapid to produce, large numbers of independent lines can be easily generated, and limitless numbers of progeny for each line can be examined under controlled genetic conditions. These features of our assay might make it useful for obtaining a rapid estimate of approximate disease severity for new PS1 and PS2 mutations, especially for those with limited pedigree data, small numbers of affected individuals, or suspected environmental or genetic confounding factors. Although the primary goal of this study was to assess an array of genetically diverse FAD mutant variants in a more standardized genetic background, the transgenic flies we characterized could be used to study the effects of suspected modifiers or search for new modifiers of PS function. The transgenic lines could also be combined with APP-expressing transgenes to investigate more directly the role of PS FAD mutants in APP cleavage, amyloidpeptide accumulation, and neurotoxicity in a fly model. The correlation we observe between the effects of different FAD mutations on Drosophila Notch signaling and human disease onset underscores recent proposals that in addition to APP processing, more global perturbations in pathways involving other g-secretase substrates should be considered in early-onset Alzheimer's disease [7] [8] [9] [10] . Finally, our results offer encouragement that additional transgenic Drosophila models might be developed to investigate clinical heterogeneity in other human diseases.
Experimental Procedures
FAD-Linked PEPC-psn Mutant Transgenes Psn FAD transgenes generated by overlapping PCR were shuttled into the vector pCaSpeR containing a Drosophila wild-type psn cDNA backbone driven by the 1.5 kb psn promoter (PEPC), and missense mutation regions were sequenced. Transgenic animals were generated by embryo injection, and additional lines were produced Table S1 for quantitative scoring). Equivalent points have been evenly dispersed for clarity (wt denotes wild-type transgene). by mobilization with D2-3 transposase. Both wild-type splice-variant cDNAs rescued psn null animals with no distinguishable difference (data not shown), so all FAD variant transgenes were made with the longer splicing variant.
Notch immunoblot analysis
Crosses were performed to generate larvae bearing a single-copy Psn FAD transgene (PEPC-psn X###Y ) in a psn B3 null background, and third-instar-larval brain-disc complexes were harvested and lysed in hypotonic buffer as described [24] . Total lysates were sonicated, and 40 mg of total protein per sample was resolved on a BioRad Criterion XT 3%-8% Tris-Acetate gel, transferred to nitrocellulose, and probed with mouse anti-Notch 9C6 antibody (1:1000 dilution) recognizing the Notch intracellular domain (University of Iowa Developmental Studies Hybridoma Bank), followed by HRPconjugated goat anti-mouse antibody (1:5000 dilution; Jackson Immunoresearch).
E(spl)m7 Semiquantitative RT-PCR Duplex PCR was performed with four concentrations of a 2-fold titration of first-strand synthesis from third-instar-larval total RNA. PCR products were visualized by SyberGreen (Molecular Dynamics) staining and quantitated with Fuji ImageQuant software, and relative absorbance units were plotted against template concentration. Slopes best fitting a straight line (R 2 R 0.95) were taken as the rate proportional to transcript levels. E(spl)m7 rates were normalized to similarly derived values for either Notch or Rp49, and final normalized data were graphed by setting psn null and wild-type control values at 0% and 100%, respectively. Data represent at least three independent PCR reactions with at least two replicated total-RNA preparations per sample (except ''severe neurogenic/adult lethal'' Rp49 normalized samples, n = 2). N ts1 animals were grown in continuous culture at five temperature increments between the permissive (19ºC) and restrictive conditions (31ºC), then harvested for RT-PCR or allowed to develop for phenotypic scoring. RT-PCR primer sequences are given in Table S2 .
Supplemental Data
Supplemental Data include two tables and are available with this article online at: http://www.current-biology.com/cgi/content/full/ 16/10/1026/DC1/.
